Suppr超能文献

纤溶酶原激活物抑制剂-1中一个功能性表位的鉴定,该表位不位于反应中心环。

Identification of a functional epitope in plasminogen activator inhibitor-1, not localized in the reactive center loop.

作者信息

Debrock S, Declerck P J

机构信息

Laboratory for Pharmaceutical Biology and Phytopharmacology, Faculty of Pharmaceutical Sciences, Katholieke Universiteit Leuven, Belgium.

出版信息

Thromb Haemost. 1998 Mar;79(3):597-601.

PMID:9531048
Abstract

Plasminogen activator inhibitor-1 (PAI-1) is unique among the serpins because of its conformational flexibility. Previously, we have characterized monoclonal antibodies that neutralize PAI-1 activity by switching the active, inhibitory pathway into the non-inhibitory substrate pathway (10). Here, we report the identification of the epitopes for two of these antibodies, i.e. MA-55F4C12 and MA-33H1 and apply this information to explain their functional effects. Using a random PAI-1 epitope library (11), phages displaying specific PAI-1 fragments were isolated after selective screening for binding onto the respective antibodies. Competition experiments with PAI-1 demonstrated that selected phages react with the antigen-binding site of the antibodies. Comparison of the sequences of the different overlapping inserts, encoding the PAI-1 epitope, with the PAI-1 cDNA sequence revealed that both epitopes, even though not identical, are located between amino acids Glu128 and Ala156 in the PAI-1 molecule. Analysis within the three-dimensional structure of PAI-1 showed that these residues completely cover helix F, which is localized close to the major beta-sheet A. This localization provides a rational basis for explaining the mechanism of PAI-1 inactivation by both antibodies: upon binding of these antibodies to PAI-1, a stabilizing effect is induced on helix F resulting in a decrease of the kinetics of insertion of the reactive site loop into beta-sheet A during interaction with the target proteinase. This forms the molecular basis for the observed functional effects of these antibodies and fully explains why PAI-1, in the presence of these antibodies, has lost its inhibitory properties but remains succeptible to cleavage by its target proteinases. The identification and localization of these functionally important epitopes opens new perspectives for the development of pharmacological agents with PAI-1 modulating properties.

摘要

纤溶酶原激活物抑制剂-1(PAI-1)在丝氨酸蛋白酶抑制剂中独具特色,因其具有构象灵活性。此前,我们已鉴定出通过将活性抑制途径转变为非抑制性底物途径来中和PAI-1活性的单克隆抗体(10)。在此,我们报告了其中两种抗体(即MA-55F4C12和MA-33H1)表位的鉴定,并运用此信息来解释它们的功能效应。利用随机PAI-1表位文库(11),在针对各自抗体的结合进行选择性筛选后,分离出展示特定PAI-1片段的噬菌体。与PAI-1的竞争实验表明,所选噬菌体与抗体的抗原结合位点发生反应。将编码PAI-1表位的不同重叠插入片段的序列与PAI-1 cDNA序列进行比较,结果显示,尽管这两个表位并不相同,但均位于PAI-1分子中第128位谷氨酸和第156位丙氨酸之间的氨基酸区域。在PAI-1三维结构内的分析表明,这些残基完全覆盖了靠近主要β折叠A的螺旋F。这种定位为解释两种抗体使PAI-1失活的机制提供了合理依据:当这些抗体与PAI-1结合时,会在螺旋F上诱导一种稳定效应,导致在与靶蛋白酶相互作用期间,反应性位点环插入β折叠A的动力学降低。这构成了观察到的这些抗体功能效应的分子基础,并充分解释了为何在存在这些抗体的情况下,PAI-1丧失了其抑制特性,但仍易被其靶蛋白酶裂解。这些功能重要表位的鉴定和定位为开发具有PAI-1调节特性的药物制剂开辟了新的前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验